BAFNA PHARMACEUTICALS LIMITED

Autres langues Bafna Pharmaceuticals Limited Bombay S.E.

Actions

BAFNAPH

INE878I01022

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:52 16/07/2024			Varia. 5j.	Varia. 1 janv.
86 ^INR	-2,60%		+0,53%	-8,34%

29/06	Bafna Pharmaceuticals Limited annonce l'interruption temporaire de ses activités sur son site de production situé à Grantlyon, Chennai	CI
29/05	Bafna Pharmaceuticals Limited approuve la nomination de A. Mohanachandran en tant que secretaire de la societe et responsable de la conformite	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bafna Pharmaceuticals Limited Announces Temporary Disruption of Operations At Manufacturing Facility Situated At Grantlyon, Chennai	29/06
Bafna Pharmaceuticals Limited Approves the Appointment of A. Mohanachandran as Company Secretary and Compliance Officer	29/05
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	29/05
Bafna Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	29/05
Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory	26/04
Bafna Pharmaceuticals Limited Announces Resignation of Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	23/04
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Bafna Pharmaceuticals Resumes Commercial Production of Manufacturing Units in Chennai, India	11/12
Bafna Pharmaceuticals Limited Announces Commercial Production	08/12
Floods Disrupt Bafna Pharmaceuticals' Manufacturing Plant in Chennai, India	07/12
Bafna Pharmaceuticals Limited Announces Suspension of Chennai Production Activity Due to Impact of Michaung Cyclone	07/12
Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Bafna Pharmaceuticals Limited Announces Resignation of Kamlesh Kumar Babulal as Non-Executive Independent Director from the Board	23/09/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23
Bafna Pharmaceuticals Limited Approves Board Appointment	27/06/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/05/23
Bafna Pharmaceuticals Limited Announces Appointment Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	07/04/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/02/23
Bafna Pharmaceuticals Limited Announces Resignation of Atul Sachdeva as Director	19/01/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action BAFNAPH
Action BAFNAPH
Actualités Bafna Pharmaceuticals Limited
Autres langues

Nos Contenus Gratuits vous Aident à Sécuriser et Augmenter la Performance de vos Investissements

Sécuriser mes Investissements

fermer